Bill
HR 3580
HR 3580 would strengthen oversight of Medicare billing-code costs to improve transparency and curb waste for CMS, providers, and beneficiaries.
HR 3580 — Oversight of Medicare Billing Code Cost Act
Summary prepared for readers seeking a clear, nonpartisan understanding of the bill
Overview
- Bill number and title: HR 3580, Oversight of Medicare Billing Code Cost Act
- Introduced: May 23, 2025
- Status: Introduced in the House; referred to committees
- Primary sponsor: Juan Ciscomani
- Cosponsors: Diana Harshbarger (cosponsor) and Lloyd Smucker (cosponsor)
Purpose and intent
- Based on the bill’s title, the legislation aims to establish or strengthen oversight of the costs associated with Medicare billing codes. The specific goals, such as improving cost transparency, preventing waste, or enhancing accuracy in Medicare billing, are not detailed in the information provided.
- Without the full text, the exact objectives, reporting requirements, and enforcement mechanisms cannot be confirmed.
Key provisions and changes (note on available detail)
- The exact statutory text and provisions are not included in the materials provided.
- It is typical for bills of this nature to address elements such as oversight responsibilities, reporting requirements, and potential adjustments to how Medicare billing codes are reviewed or audited. However, no specific provisions (e.g., new data collection mandates, independent audits, thresholds, penalties, or timelines) are listed here.
- Once the bill’s text is available, the key provisions can be summarized precisely (e.g., which agency would oversee costs, what reports or audits would be required, and any compliance deadlines).
Who would be affected
- Medicare program and its administration (likely CMS) would be the primary focus of any cost oversight.
- Healthcare providers and suppliers billing Medicare could be indirectly affected, depending on the oversight mechanisms (e.g., new reporting requirements, audits, or cost controls).
- Beneficiaries could experience indirect effects through potential changes in Medicare billing practices or costs, though specific impacts are not detailed in the provided materials.
Procedural and timeline aspects
- Committee referrals: The bill was referred to the House Committee on Ways and Means and, in addition, to the Committee on Energy and Commerce, for consideration of provisions within each committee’s jurisdiction.
- Timing: The referral notes indicate a period to be determined by the Speaker for committee consideration.
- Next steps: If advanced, the bill would move through committee processes, potentially to floor consideration, amendments, and a vote, before crossing to the Senate (if applicable) or broader legislative action.
Sponsors
- Primary sponsor: Juan Ciscomani
- Cosponsors: Diana Harshbarger, Lloyd Smucker
Notes
- The summary reflects only information provided in the bill’s basic details. For a precise understanding of the bill’s actual provisions, text from the introduced version is needed. If you can share the full text or a more detailed summary, I can provide a deeper, clause-by-clause analysis.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
